GSK Plc ADR

GSKNYSE · USD
48.72USD-0.63 (-1.28%)
799

GSK Plc ADR (GSK) Covered Calls

As of September 29, 2026, GSK has 62 covered call opportunities in the coming three months. Return ranges from 0.9 to 83.3% until expiration. Annualized return ranges from 5.5 to 205.1%. The nearest expiration is October 2, 2026. Maximum potential profit is $4,101.

Read more

Running GSK covered calls helps you generate consistent income from GSK Plc ADR's shares you already own, turning a long stock position into a yield-producing asset. A covered call on GSK Plc ADR involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best GSK covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if GSK stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling GSK covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given GSK Plc ADR covered call is worth writing.

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections.

It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

Income-focused investors, long-term GSK holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling GSK covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best GSK Plc ADR covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - General
  • SectorHealthcare
  • IV percentile60.32% Neutral
  • Market cap (M$)98,873
  • 52 weeks high-20.02%
  • 52 weeks low18.20%
  • Analyst recommendationHold
    2.57
  • Target price$58.67
    19.05% above the current stock price
  • Dividend—
  • Payout ratio46.93%
  • Earnings date2026-10-28
  • P/E15.55
  • Future P/E9.64
  • EPS (ttm)3.17
  • EPS growth next 5 years4.72%

As of September 29, 2026

2026-10-162155.0011.700.050.10581.0011.80205.08-0.10+0.064840.05
2026-10-02751.003.570.050.25181.003.68191.67-0.10+0.171280.20
2026-10-162154.009.670.050.20481.009.77169.79-0.10+0.09460.15
2026-10-232855.0011.700.052.20581.0011.80153.81-0.10+0.27132.15
2026-10-091452.005.610.050.55281.005.71148.78-0.10+0.191110.50
2026-11-205660.0021.850.100.201086.0022.06143.75-0.20+0.065,2540.10
2026-10-162153.007.640.150.25391.007.94138.02-0.30+0.131480.10
2027-02-1914775.0052.320.050.202581.0052.42130.15-0.10+0.03120.15
2026-10-02750.001.540.250.65101.002.05106.95-0.51+0.36250.40
2026-10-162152.005.610.250.40301.006.11106.25-0.51+0.209040.15

As of September 29, 2026

Sell covered calls with the data behind you

Find the best GSK covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial